期刊文献+

尿脱落细胞荧光原位杂交技术在尿路上皮癌诊断中的应用 被引量:2

Fluorescence in situ hybridization of urine exfoliative cells in diagnosis of urothelial carcinoma
原文传递
导出
摘要 目的:分析尿脱落细胞荧光原位杂交技术(FISH)在尿路上皮肿瘤诊断中的应用价值。方法:对205例临床疑诊尿路上皮肿瘤患者的尿脱落细胞进行FISH检测,并与组织病理学结果进行对照,总结FISH检测方法对尿路上皮癌诊断的敏感性与特异性。结果:153例尿路上皮癌、52例非尿路上皮癌患者在术前接受了尿脱落细胞FISH检测,术后均经病理检查确定诊断。FISH检测尿路上皮癌的敏感性为54.2%,特异性为94.2%。结论:尿脱落细胞FISH检测对于诊断尿路上皮癌具有高度的特异性。 Objective:To investigate the value of fluorescence in situ hybridization of urine exfoliative cells in the diagnosis of urothelial carcinoma. Method:The urine samples were collected from 205 patients with suspected urothelial neoplasms. The specificity and sensitivity of FISH were analyzed on the basis of pathological diagnosis. Result: One hundred and fifty-three patients with urothelial carcinoma and 52 cases of non-urothelial neoplasms received one FISH assay of their urine exfoliative cells before operation. The sensitivity of FISH examination of malignant epithelial tumor was 54.2%. The specificity of FISH on urothelial carcinoma was 94.2%. Conclusion:The FISH assay of the urine exfoliative cells shows high specificity for the detection of urothelial carcinoma.
出处 《临床泌尿外科杂志》 2012年第10期753-755,共3页 Journal of Clinical Urology
关键词 膀胱肿瘤 荧光原位杂交 尿路上皮癌 bladder cancer fluorescence in situ hybridization urothelial carcinoma
  • 相关文献

参考文献12

  • 1PLANZ B,JOCHIM S E,DEIX T,et al. The role of urinary cytology for detection of bladder cancer[J]. Eur J Surg Oncol, 2005,31 t304--308.
  • 2王鹏,靳风烁,叶锦,吴刚,李彦锋,张尧,梁平.荧光原位杂交检测尿脱落细胞染色体异常诊断膀胱肿瘤的研究[J].第三军医大学学报,2009,31(10):948-951. 被引量:16
  • 3HALLING K C,KING W,SOKOLOVA I A,et al. A comparison of cytology and fluorescence in situ hy- bridization for the detection of urothelial carcinom[J].J Urol, 2000,165 : 1768-1775.
  • 4SAROSDY M F, KAHN P R,ZIFFER M D, et al. Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with he- maturi[J]. J Urol, 2006,176 : 44 -- 47.
  • 5SOKOLOVA I A, HALLING K CJ.FENKINS R B, et al. The development of a multitarRet,multicolor fluo- rescence in situ hybridization assay for the detection of umthelial carcinoma in urine[J].J Mol Diagn, 2000,2:116-- 123.
  • 6SAUTER G, GASSER T C, MOCH H, et al. DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH [J].Uml Res, 1997, 2S (suppl 1) :S37--S43.
  • 7BUBENDORF L,GRILLIB, SAUTER G,et aL Mulr tiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washing[J]. Am J Clin Pathoi,2001,116:79--86.
  • 8BERGMAN J,REZNICHEK R C, RAJFER J. Sur- veillance of patients with bladder carcinoma using flu- orescent iwsitu hybridization on bladder washings [J]. BJU Int, 2008,101 : 26-- 29.
  • 9FRITSCHE H M,BURGER M,DIETMAIER W,et al. Multicolor FISH(UroVysion) facilitates follow-up of patients with high-grade urothelial carcinoma of the bladder[J].Am J Clin Pathol, 2010,134: 597 -- 603.
  • 10CARAWAY N P,KHANNA A,FERNANDF_2. R L, et aL Fluorescence in situ hybridization [or detecting urothelial carcinoma: a clinicopathologic study[J].Cancer Cytopathol,2010,118: 259--268.

二级参考文献31

  • 1张业贵,毕新刚,韩亚玲,蔡岩,徐昕,吴玉鹏,杨壹羚,马建辉,赵平,贾雪梅,王明荣.多色荧光原位杂交在膀胱尿路上皮癌诊断中的应用[J].癌症,2007,26(2):189-193. 被引量:27
  • 2Daniely M, Rona R, Kaplan T, et al. Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology [ J ]. Cancer, 2007,111 (6) : 517 - 524.
  • 3Lotan Y, Bensalah K, Ruddell T, et al. Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder[J]. J Urol, 2008,179(6) : 2164 -2169.
  • 4Zhang J, Zheng S, Gao Y, et al. A partial allelotyping of urothelial carcinoma of bladder in the Chinese [J]. Carcinogenesis, 2004, 25 (3) : 343 - 347.
  • 5熊洪燕,易东.医学科研方法-设计、测量与评价[M].重庆:西南师范大学出版社,2005:42-45.
  • 6Kruger S, Mess F, Bohle A, et al. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder [J]. Int J Oncol, 2003, 23(1):41 -48.
  • 7Veeramachaneni R, Nordberg M L, Shi R, et al. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma[J]. Diagn Cytopathol, 2003, 28(6) : 301 -307.
  • 8Mhawech-Fauceglia P, Fischer G, Beck A, et al. Raft, Aurora-A/STK15 and E-cadherin biomarkers expression in patients with pTa/pT1 urothelial bladder carcinoma; a retrospective TMA study of 246 patients with longterm follow-up[J]. Eur J Surg Ongol, 2006, 32(4) : 439 -444.
  • 9Sauter G, Haley J, Chew K, et al. Epidermal-growth-factor-receptor expression is associated with rapid tumor proliferation in btadder cancer[J]. Int J cancer, 1994, 57(4) :508 -514.
  • 10Gallucci M, Guadagni F, Marzano R, et al. Status of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parameters[J]. J Clin Pathol, 2005, 58(4) : 367 -371.

共引文献20

同被引文献24

  • 1Morgan Rouprêt,Marko Babjuk,Eva Compérat,Richard Zigeuner,Richard Sylvester,Max Burger,Nigel Cowan,Andreas B?hle,Bas W.G. Van Rhijn,Eero Kaasinen,Joan Palou,Shahrokh F. Shariat.European Guidelines on Upper Tract Urothelial Carcinomas: 2013 Update[J].European Urology.2013(6)
  • 2Giovanni Lughezzani,Maximilian Burger,Vitaly Margulis,Surena F. Matin,Giacomo Novara,Morgan Roupret,Shahrokh F. Shariat,Christopher G. Wood,Richard Zigeuner.Prognostic Factors in Upper Urinary Tract Urothelial Carcinomas: A Comprehensive Review of the Current Literature[J].European Urology.2012(1)
  • 3Jeffery C. Wheat,Alon Z. Weizer,J. Stuart Wolf,Yair Lotan,Mesut Remzi,Vitaly Margulis,Christopher G. Wood,Francesco Montorsi,Marco Roscigno,Eiji Kikuchi,Richard Zigeuner,Cord Langner,Christian Bolenz,Theresa M. Koppie,Jay D. Raman,Mario Fernández,Pierre Karakiewizc,Umberto Capitanio,Karim Bensalah,Jean-Jacques Patard,Shahrokh F. Shariat.Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy[J].Urologic Oncology: Seminars and Original Investigations.2012(3)
  • 4Chuanliang Xu,Qinsong Zeng,Jianguo Hou,Li Gao,Zhensheng Zhang,Weidong Xu,Bo Yang,Yinghao Sun.Utility of a Modality Combining FISH and Cytology in Upper Tract Urothelial Carcinoma Detection in Voided Urine Samples of Chinese Patients[J].Urology.2011(3)
  • 5Michelle D. Reid-Nicholson,Nisrin Motiwala,Scott C. Drury,Stephen C. Peiper,Martha K. Terris,Jennifer L. Waller,Preetha Ramalingam.Chromosomal abnormalities in renal cell carcinoma variants detected by Urovysion fluorescence in situ hybridization on paraffin-embedded tissue[J].Annals of Diagnostic Pathology.2011(1)
  • 6Ramy F. Youssef,Shahrokh F. Shariat,Yair Lotan,Christopher G. Wood,Arthur I. Sagalowsky,Richard Zigeuner,Cord Langner,Francesco Montorsi,Christian Bolenz,Vitaly Margulis.Prognostic Effect of Urinary Bladder Carcinoma In Situ on Clinical Outcome of Subsequent Upper Tract Urothelial Carcinoma[J].Urology.2011(4)
  • 7Christine Mian,Guido Mazzoleni,Silke Vikoler,Thomas Martini,Ruth Knüchel-Clark,Dirk Zaak,Alexander Lazica,Stephan Roth,Michael Mian,Armin Pycha.Fluorescence In Situ Hybridisation in the Diagnosis of Upper Urinary Tract Tumours[J].European Urology.2010(2)
  • 8Sean R. Williamson,Rodolfo Montironi,Antonio Lopez-Beltran,Gregory T. MacLennan,Darrell D. Davidson,Liang Cheng.Diagnosis, evaluation and treatment of carcinoma in situ of the urinary bladder: The state of the art[J].Critical Reviews in Oncology and Hematology.2010(2)
  • 9EnriquePieras,GuillermoFrontera,XaviRuiz,AntoniVicens,MarianoOzonas,PedroPizá.Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma[J].BJU International.2010(9)
  • 10Bin Luo,Wen Li,Chun-Hua Deng,Fu-Fu Zheng,Xiang-Zhou Sun,Dao-Hu Wang,Yu-Ping Dai.Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma[J].Cancer Genetics and Cytogenetics.2009(2)

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部